Monday, August 5, 2013
Sanofi starts late-stage test for Clostridium vaccine
PARIS |
(Reuters) - Sanofi said on Monday it had started late-stage trials involving 15,000 people to test a vaccine against Clostridium difficile infections (CDI), the main cause of diarrhea in hospitals.
There are currently no vaccines available against the Clostridium difficile bacteria, while increasing antibiotic resistance is making it harder to treat the condition.
Combined data from the United States and European Union show that healthcare systems spend more than $7 billion annually to treat CDI cases.
(Reporting by Elena Berton; editing by Elizabeth Piper)
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html
